CRON
Cronos Group IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.00B
P/E Ratio
0.00
EPS
$0.00
Beta
1.25
52W High
$3.43
52W Low
$1.84
50-Day MA
$2.68
200-Day MA
$2.62
Dividend Yield
—
Profit Margin
-1.14%
Forward P/E
26.25
PEG Ratio
—
About Cronos Group Inc
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
Fundamentals
| Revenue (TTM) | $159.53M |
| Gross Profit (TTM) | $63.20M |
| EBITDA | -2,000 |
| Operating Margin | -1.10% |
| Return on Equity | 0.45% |
| Return on Assets | -0.78% |
| Revenue/Share (TTM) | $0.42 |
| Book Value | $2.85 |
| Price-to-Book | 0.96 |
| Price-to-Sales (TTM) | 6.28 |
| EV/Revenue | 1.338 |
| EV/EBITDA | 1.90 |
| Quarterly Earnings Growth (YoY) | 126.80% |
| Quarterly Revenue Growth (YoY) | 40.10% |
| Shares Outstanding | $373.66M |
| Float | $192.24M |
| % Insiders | 48.60% |
| % Institutions | 15.77% |
Historical Volatility
HV 10-Day
31.45%
HV 20-Day
33.51%
HV 30-Day
37.05%
HV 60-Day
40.80%
HV Rank
40.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($2.44 target)
3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026